Kyle Richard G

Kyle Richard G. has been an active seller of Timken Company (TKR) stock, with open-market sales totaling roughly $10.8 million across six transactions between February and May 2026. The largest dispositions occurred on May 8 ($4.36 million) and February 6 ($3.22 million), with additional sales on February 19 ($1.07 million), February 20 (two trades worth $2.12 million combined), and May 27 ($1.08 million). These sales were supplemented by routine tax-withholding events (code F) that removed another $2.6 million in shares during February, though those are automatic and not discretionary. Notably, Kyle has recorded zero open-market purchases (code P) across his 84 total filings, and his only acquisitions have been compensation-related grants (code A) valued at roughly $155,000 across Sonoco Products (SON) and Timken. The pattern across his three holdings—Timken, Sonoco, and Sotera Health (SHC)—shows a clear asymmetry: consistent six-figure and seven-figure sales in TKR, modest recurring equity awards in SON (quarterly grants of $14,000–$36,000), and a single zero-value grant in SHC. His most recent activity, as of July 2026, consists entirely of SON compensation awards, with the last TKR sale occurring on May 27. Over the full filing history, Kyle has sold $23.3 million in stock while acquiring only $584,757 through compensation, producing a net cash outflow from his holdings of over $22.7 million. The absence of any open-market purchases, combined with the steady stream of sales, indicates a sustained distribution posture rather than accumulation, though the sales are spread across several months rather than clustered in a single event.